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Abstract: In this study, the Bioeutectic® blocks were inserted into the critical size defects 
of eight rabbits, using both tibiae, and the physical and chemical nature of the remodeled 
interface between the Bioeutectic® implants and the surrounding bone were performed at 
four and 15 months. The results showed a new fully mineralized bone growing in direct 
contact with the implants. The ionic exchange, taking place at the implant interface with 
the body fluids was essential in the process of the implant integration through a 
dissolution-precipitation-transformation mechanism. The study found the interface 
biologically and chemically active over the 15 months implantation period. The 
osteoblastic cells migrated towards the interface and colonized the surface at the contact 
areas with the bone. The new developed apatite structure of porous morphology mimics 
natural bone. 
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1. Introduction 
Silicon (Si) containing and/or silicon-substituted calcium phosphates (Si-CaP) materials have 
attracted considerable interest for orthopaedic, oral and maxillofacial applications because of their 
biocompatibility and tight bonding to bone, resulting in the growth of healthy tissue directly onto their 
surface, however many outstanding problems still remain unresolved. The most important is the 
process of total osseointegration of ceramic implants in the human body [1–5]. 
When dense bioactive materials are implanted into living body, the interaction between bone tissue 
and these materials usually starts on their surfaces, with the remaining bulk of the material unchanged, 
often causing a harmful shear stress [3–5], hence, bioactive materials with interconnected porosity in 
their structure have better potential in hard tissue prostheses [6–8]. 
The porous structure of bioactive materials provides a template for fibro-vascular ingrowths, which 
can result in the deposition of new lamellar bone when followed by osteoblasts’ differentiation [9,10]. 
Porous implants are highly favorable over non-porous type because of the following [6–10]: (a) porous 
materials have large surface area resulting in a high tendency to bioresorb, therefore, inducing higher 
bioactivity rate; (b) interconnected pores can provide a framework for bone growth into the matrix of 
the implant, and, thus, anchor the prosthesis with the surrounding bone, preventing loosening of 
implants; (c) interconnected porosities act like an organization of vascular canals, which can ensure the 
blood and nutrition supply for the bone. To serve all these purposes the minimum pore size required in 
order to regenerate mineralized bone is generally considered to be in the range of 50–100 μm [6–10]. 
The applications of porous bioactive materials have been restricted as a result of their low fracture 
strength and fatigue resistance. A new way of making strong porous ceramics with interconnected 
porosity has been developed by De Aza et al. [11–13]. This is based on designing dense bioactive 
ceramic materials with the ability to develop in situ porous hydroxyapatite-like (HA) structure,  
once the materials are implanted into living body. This material is composed of two phases, 
pseudowollastonite (α-CaSiO3 = psW) of bioactive properties, and α-tricalcium phosphate (α-TCP) of 
resorbable properties. 
It was found, that during the material exposure to the dynamic simulated body fluid (SBF) for two 
weeks a complete transformation of the eutectic material takes place, giving rise to a hydroxyapatite 
porous bone. (Figure 1) [14]. 
Figure 1. Transformation of the bioeutectic® material after soaking for two weeks in SBF 
into a structure similar to hydroxyapatite porous bone. 
 
Materials 2014, 7 2397 
 
 
The purpose of the present study was to examine the material osseintegration due to physical and 
chemical changes taking place at the Bioeutectic® implant-bone interface. It is expected that this 
material will behave in a similar way as it did in the “in vitro” tests, facilitating the osteointegration of 
the implant. Consequently, the material may present an interesting alternative in biomedical applications. 
2. Results 
SEM morphological observation of the Bioeutectic® material as manufactured showed dense 
structure constituted of quasi-spherical colonies with an average diameter of ~15 ± 5 μm (Figure 2A). 
The colonies contained alternating radial lamellae of psW and α-TCP, with an average width of about 
1.5 and 0.9 μm, respectively. The morphology of the material corresponded to a fully dense lamellar 
eutectic structure. SEM-EDX microanalysis showed that the gray phase, as displayed in the images, 
was composed of psW (●), while the interlocking black phase, that is clearly visible in the micrograph 
after the chemical etching with dilute acid acetic, was composed of α-TCP (○) (Figure 2B). 
Figure 2. Microstructure of the Bioeutectic® material before implantation chemically etched 
with dilute acid acetic (○ = TCP; ● = psW). (A) low magnification; (B) high magnification. 
 
All animals survived the 15 months study period without any evidence of inflammation or infection 
at the implantation sites. 
After four months of the implantation, the formation of a thin layer of immature bone tissue around 
the Bioeutectic implant was observed, directly onto the implant surface. After staining, this new layer 
showed a similar affinity to that of animal bone extracellular matrix surrounding the Bioeutectic 
implant. Figure 3 presents results of the haematoxylin-eosin stained cross-section of the implant after  
4 months of implantation. Figure 3 shows the lower part of the implanted cylinder with the  
newly-formed bone covering the entire part of the defect. A detail of the implant medullar 
hematopoyetic tissue interface covered with a new immature bone tissue is presented in Figure 3B. It is 
important to highlight the absence of any inflammatory cells or formation of any fibrous connective 
tissue in the vicinity of the implanted material and around the newly formed woven bone, which 
otherwise would imply intolerance of the bone tissue towards the implant. 
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Figure 3. Haematoxylin-eosin stained cross-sections of the implant after four months  
of implantation. (A) Lower part of the implant; (B) Middle part of the implant. 
 
The macroscopic image of the transverse cross- section of the implantation zone after the 15 months 
periods (Figure 4A) showed that the implanted material (I) strongly adhered to the cortical bone (CB). 
Figure 4B,C shows the adjacent woven bone formed next to the cortical bone, without interposition of 
any fibrous tissue, indicating a good osteointegration of the Bioeutectic® implant. 
Figure 4. (A) Low magnification image of the implant section after 15 months of 
implantation; (B) upper portion of the implant in close contact to the cortical bone;  
(C) close contact between the implant and cortical bone in the lower part of the implant  
(I: implant, CB: Cortical bone, BM: Bone marrow). 
 
After 15 months of the implantation (Figure 5), the general architecture of the implanted material 
was still visible, although in some areas an irregular surface morphology in contact with the adjacent 
bone was observed. This was caused by the gradual degradation of the material, due to its progressive 
reabsorption and substitution by the new mineralized bone tissue, forming trabeculars like natural bone 
(creeping substitution process). In addition, a high osteoblastic activity and an increase in the quantity 
of the newly-formed bone tissue in the periphery of the material, between the implant from the 
hematopoyetic bone marrow, was present. Figure 5A shows the implant (I) located at the 
centromedular area of the bone surrounded by newly formed bone tissue (*). The transforming implant 
surface, as a consequence of the reabsorbing process, and a new bone tissue formation around the 
implant surface (arrow), without interposition of fibrous tissue, is shown in Figure 5B; Figure 5C 
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shows a detail of the implant (I)—hematopoyetic bone marrow interface (*) with the new bone like an 
osteon (arrow), growing characteristically into the implant (colonization process). 
Figure 5. The histological cross-sections of the 15-month implant in bone. (A,C) stained 
with haematoxylin-eosin; (B) stained with Masson Trichrome. (I: implant, BM: Bone marrow). 
 
A strong correlation was found between the SEM implantation results at 4 months and the relevant 
histological findings. The SEM observation of the 4 month implant showed the new immature bone 
covering the Bioeutectic® implant, as displayed in Figure 6A. After 15 months of implantation, the 
whole surface of the ceramic implant was covered by the newly-formed bone tissue (Figure 6B), as the 
bone deposition process continued. 
Figure 7 shows the back scattered SEM cross-section images of the interface between the natural 
bone tissue and the Bioeutectic® implant after four months of implantation. The low magnification 
image clearly shows the reaction zone at the surface of the ceramic implant composed of two different 
layers in direct contact with each other. The layers are marked, respectively, as B and C in Figure 7A. 
The higher magnification image in Figure 7B shows the interface microstructure between the 
ceramic implant and the intermediate layer (B) that presents similar morphology of the eutectoid 
colonies like the morphology of the original implant (Figure 2). Figure 7C shows the newly formed 
porous bone tissue microstructure in the region (C). 
EDS analysis of the implant and the two layers confirmed the chemical compositions of the new 
bone, the underlayer and the implant substrate. The underlayer (B) was composed of a Ca-P-Si 
compound, while the new bone over the layer was also composed of the same Ca-P-Si elements but 
with silicon at relatively low concentration. Quantitative elemental EDS analysis performed at 
Bioeutectic- bone tissue interface confirmed that the interface remained chemically active over the 
four-month implantation time. Table 1 lists the Ca/P ratios and Si ion concentration obtained in the 
bone region at the interface after four months. The microanalysis results indicated that newly grown 
bone surrounding the implant did not reach the same degree of mineralization within a distance of  
150 μm from the interface. The relative Ca/P ratio in the mature area 150 μm away from the interface 
reach the value of 2.0. In areas closer to the interface, the ratio consistently increased with decreasing 
distance from the interface to 2.4 at the interface. Also, Si ion concentration decreased with increasing 
distance from the implant meaning partial dissolution of psW phase. 
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Figure 6. SEM images of the Bioeutectic implant after (A) four months of implantation 
showing the implant surface partially covered by an immature bone tissue; (B) at 15 months of 
implantation showing the whole surface of the implant covered by a newly formed bone tissue. 
 
Figure 7. Back-scattered SEM images and EDS analyses of the cross-section of Bioeutectic 
implant showing the new bone tissue in direct contact with the implant after four months  
of implantation. 
 
Table 1. EDS elemental analysis of the implant-bone interface after four months of study. 
EDS elemental 
analysis 
Zone B Zone C 
Down Up Down Up 
Ca/P 2.4 2.3 2.1 2.0 
Si (wt%) 0.59 ± 0.01 0.26 ± 0.01 0.04 ± 0.01 0.01 ± 0.01 
Figure 8 shows the SEM microstructure of the polished cross-section of the 15-month implant. The 
individual X-ray maps of the silicon, calcium and phosphorous distribution are also included. This 
compositional micro-characterization of the interface showed that there were two chemically separate 
layers formed on the implant surface. The outer layer contained Ca and P with some traces of Si, while 
the under layer was rich in Ca, P, and Si. These results agreed with the histological observation described in 
the study earlier on, confirming formation of the bone phase directly at the implant—natural bone interface. 
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Figure 8. X-ray elemental maps of Si, Ca, P and SEM image of a cross-section of Bioeutectic 
implant after 15 months of implantation. (A,B) indicate places where micro-Raman spectra 
were taken. 
 
Figure 9 shows the Micro-Raman spectra collected from of the reaction zone in Figure 8, after  
15 months of implantation. Standard TCP and HA are also enclosed for comparative purpose. It is 
important to emphasize that this technique allowed on differentiation between the original α-TCP 
phase in the pellets and HA-like reaction products [15–17]. The strong peak observed in Figure 9 at 
962 cm−1 is assigned to symmetric stretching PO43− modes, and the bands observed in the frequency 
regions 400–500, 570–625, 1020–1095 cm−1 are assigned respectively to ν2−, ν4−, and ν3− type internal 
PO43− modes, in agreement with the bibliographic data bases [15–17]. The O–H stretching mode 
produces an intense Raman peak at 3576 cm−1wich is absent from TCP. Consequently, a selective 
solution of the psW in the medium takes place, leaving a residual phase of HA-like, pseudomorphic 
with the original α-TCP phase. 
Further identification of the Ca-P phase was carried out by examining thin sections in the 
transmission electron microscope. This study confirmed that the newly-formed phase mimicked bone 
from morphological and structural point of view. The bright field image of the stained Ca-P and 
implant interface is shown in Figure 10A. Collagen fibers with characteristic banding are well resolved 
in the micrograph. In addition, the selected area diffraction pattern of an unstained thin sections 
contains the new phase at the interface, Figure 10B, gave rise to typical arcing in the (002) direction 
due to preferential orientation of the nano-apatite crystals in the matrix of collagen fibers. 
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Figure 9. (A,B) Micro-Raman spectra of the reaction zone after 15 months of implantation. 
Micro-Raman spectra of Standard TCP and HA is also included. 
 
Figure 10. (A) Transmission electron micrograph of the stained interface at the 15th month, 
showing well resolved collagen fibers in the new formed Ca-P phase; (B) Equivalent selected 
area diffraction pattern of the new bone tissue; unstained thin section. 
 
3. Discussion 
The Laser Floating Zone Method enables us to obtain, in the solidification front, very high axial and 
radial thermal gradients allowing considerable growth speeds compared with other methods or heating 
sources. On the other hand, the absence of crucibles minimizes the contamination of the samples. This 
is a very important aspect of the procedure, leading to chemical and structural perfection of the 
manufactured samples. On the contrary, once of the limitations of the manufacture technique is the 
diameter size of the cylindrical bioeutectic specimens. 
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The choice of the New Zealand rabbit model provides a quick and reproducible model for testing 
bioengineering materials [18,19]. A defect can be defined as critical when it cannot close spontaneously, 
a situation that is conditioned by specific bone and characteristics of the subject. In the case of New 
Zealand rabbit model, critical size has been established as 6 mm [19] Due to processing limitations of 
the method used for the manufactured of the material a housing defect of 3 mm has been used [18]. 
This defect size facilitated observation of the biomaterial’s activity without interfering in the process 
of new bone formation but achieving adequate absorption. 
A long-term implantation of up to 60 weeks (15 months) was carried out in this investigation, in 
view of the fact, that the average time required for the integrating of an orthopedic implant in human 
body is on average three months, while this time is reduced to about four to six weeks in animal 
models, like rabbits. The experimental observations proved that the implanted material in vivo 
simulation displays strong osseointegration capability. It is also known, that faster bone regeneration at 
the implanted region, due to the large capacity of bone remodeling in these specimens animals of this 
weight (3.5 kg equate to an age of 3 months), thus, improving the osseointegration efficacy of the 
implanted material. In addition, it has taken an intermediate time of four months to see the evolution of 
the material and not just the final state of the material at 15 months. 
The commonly proposed bioactivity mechanism for the Ca-P bioceramics involves initially 
dissolution of calcium and phosphate ions [1–3] from the material. A subsequent supersaturation of 
these ions in the vicinity of an implant leads to their precipitation and formation of the biological 
apatite both heterogeneously on the surface of the implant and also on proteins nearby [20]. 
Subsequently, this modified surface rapidly absorbs more protein and promotes cell adhesion [21], 
particularly osteoblasts, which are associated with bone formation and implant bonding [22,23]. 
In the present study the thickness of the new layer increased significantly during over the first 
period of four months, from zero to just under 150 μm (Figure 7). From the 4th onwards, the overall 
reaction rate slowed down. The thickness of the reaction zone at 15 months of implantation reached 
about 200 μm (±5 μm), of which 120 μm (±5 μm) corresponded to the mineralized new bone tissue 
and 80 μm (±5 μm) to the under layer of the mature bone tissue (Figure 8). The reaction rate within  
the first four months was estimated to be about 9 μm per week, compared with 1 μm per week over the 
next 11 months of implantation. 
The already published studies found that an appropriate concentration of silicon in the biomaterial 
acts as a stimulant for bone matrix integration because of the ion exchange mechanism with the 
surrounding environment [23–25]. Our extensive literature review on soluble factor effects showed 
that Si concentrations <19 ppm or Ca concentrations ~250–600 ppm favor osteoblastic differentiation 
and viability [24–32]. Thus, it appears that there is an optimal concentration range for these soluble 
elements, within which the cells’ differentiation is stimulated. 
This study found a release of Ca, P, and Si ions, which was seen to promote new bone growth; it is 
possible that high levels of Ca and P stimulate osteogenesis due to their effects on osteoblast  
gene expression, as described by Lazary et al. [32]. In normal calcified bone, the Ca/P molar ratio 
increases with increasing calcification. For all these elements, the presence of silicon is fundamental, 
as it effectively promotes mineralization processes. Furthermore, psW-TCP in block form offers 
biocompatibility, has sufficient mechanical strength and does not produce any adverse inflammatory 
reactions at the insertion site; the fact that it is absorbable allows its rapid replacement by new bone 
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without causing any reactions to foreign bodies. For this reason, little or no inflammatory reaction was 
observed; this was also true of the control samples. Its rapid replacement by new bone allows a bone 
matrix to become established within the material, giving the receiving area physical properties similar 
to the bone. As we have seen the incorporation of silicon improves the material’s integration and 
compatibility, and enhances the properties of TCP, which is otherwise reabsorbed too quickly and is 
less stable. 
The reason for the higher Ca/P ratio might be two-fold. The first important factor is continuous Ca 
ions release from the psW implant. Secondly, the bone could enrich itself with carbonate ions, 
producing carbonate enriched HA. The mechanism of the formation of the porous new bone can be 
summarized in the following steps: The psW phase in contact with bone starts to react via an ionic 
exchange of 2H3O+ from the medium for one Ca2+ from the psW network. This reaction starts at the 
surface of the material, and progresses deeply into the material, in the confined channels between the 
α-TCP lamellae as psW is dissolved. Next, the α-TCP lamellae start to react with the Ca2+ and OH− 
ions present in the confined channels. Thus, a pseudomorphic transformation of α-TCP into apatite 
occurs (Figures 7 and 8). The silicon not involved in the reaction, migrate through the medium away 
from the interface but the diffusion of the ions across the interface can stop due to the thickness and the 
structure of the new bone layer. This can be the reason why we found Si in the under layer (Zone A in 
Figure 8). Next, the bone could enrich itself with carbonate ions, producing carbonate enriched HA of 
variable CO32− content, and hence giving rise to variable Ca/P ratios, greater than of pure HA, by 
substituting PO43− for CO32− groups (Table 1). 
The indication was that the process of the new bone formation at the interface would continue for as 
long as the ion exchange mechanism between the implant and the body fluids takes place, assuming 
that the implant continues to remain in a biologically healthy environment. It is expected that this 
process will come to the end when the supply of Ca, P, and Si ions from the implant part into the 
surround terminates. This can occur when the whole implant underwent transformation into the bone 
phase, and therefore fulfilled its function as the hard tissue substitute material, or if the diffusion of the 
ions across the interface stopped due to the thickness and the structure of the new bone layer. These 
results suggested that the Bioeutectic® ceramic remains histologically and morphologically active in 
the natural hard tissue environment and bonds directly to bone through a Ca-P rich layer containing a 
trace of Si, mimicking the natural bone in morphology and composition. 
In addition, the results from this study indicated that, a solution-mediated effect of the soluble 
silicate ions on the bone remodeling was important as the silicate ions come from dissolution of the 
psW phase, hence, may also play a role in accelerating the process of the bone mineralization around 
the implant. Studies by Carlisle, using electron probe microanalysis, have highlighted that silicon plays 
an integral role during the bone mineralization processes [33,34]. Silicon is essential for the growth and 
development of certain biological tissues, such as bone, teeth and some invertebrate skeletons. A recent 
investigation showed that dietary silicon intake is positively associated with cortical mineral density 
subject to availability of estrogens in humans [35]. The current study proved that silicon was present in 
various concentrations in all phases formed on the ceramic surface during the implantation  
(Figure 7B,C at four month, Figure 8 (elemental mapping of Si) at 15 month, and also Table 1). 
Although the current paper emphasizes the influence of silicate ions in accelerating the process of the 
apatite formation on the surface of the implant, it is important to consider both the cell and solution 
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mediated effects of Ca-P-Si ions on the processes of the Bioeutectic osseointegration as it is likely that 
these two processes occur in parallel at the implant–tissue interface. 
The new bone had a similar Ca/P ratio to a natural HA (carbonated hydroxyapatite) and lattice 
planes of (002) type, related to 0.344 nm spacing of crystalline particle in bone [25,36–38]. For all 
these elements, the presence of silicon is fundamental, as it effectively promotes mineralization processes. 
Furthermore, Bioeutetic in block form offers biocompatibility, has sufficient mechanical strength, and 
does not produce any adverse inflammatory reactions at the insertion site. Its rapid mimic 
transformation in a new bone allows a bone matrix to become established within the material, giving 
the receiving area physical properties similar to the bone [39]. 
Biocompatibility of the material in bone at 15 months post-implantation was determined by the 
absence of necrosis and inflammation, particularly macrophages and foreign body type of giant cells 
(FBG). The ability of the material to integrate with the surrounding host bone, otherwise known as 
osseointegration, was determined by the presence of newly formed bone at the host bone-material 
interface. The absence of macrophages and fibrous tissue at 15 months post-implantation around the 
Bioeutectic ceramic and deposition of the new bone at the interface, indicates the biocompatible nature 
of the material and its good osseointegration properties. 
4. Experimental Section 
4.1. Bioeutectic® Preparation 
The starting materials were composed of tricalcium phosphate of high-purity (Merck, Darmstadt, 
Germany) and synthetic pseudowollastonite (the high temperature polymorph of the chain-silicate 
mineral wollastonite). The psW was synthesized by a solid-state reaction from the stoichiometric 
mixture of silicon oxide (99.9 wt%, Strem Chemicals Inc, Newburyport, MA, USA) and calcium 
carbonate (99.5 wt%, Merck, Darmstaadt, Germany). The powders were attrition milled with  
PSZ-zirconia balls in isopropyl alcohol medium, dried, isostatically pressed at 200 MPa and heated in 
platinum crucibles at a rate of 5 °C/minute up to 1500 °C over a four hour period. Next, the psW 
compound was ground, pressed and reheated again. This procedure was repeated a number of times 
until the X-ray diffraction analysis (XRD) showed the presence of only the psW phase. 
Ceramic precursor rods, 3 mm in diameter and 50–100 mm in length, were prepared from the powder 
mixture of psW and TCP of the eutectic composition (80 CaSiO3 + 20 Ca3(PO4)2 in mol%) by pressureless 
sintering at 1200 °C for 12 h. Eutectic composition and melting point were obtained from the calcium 
silicate (CS)–Tricalcium phosphate (TCP) phase diagram presented by De Aza et al. [40]. 
The laser floating zone (LFZ) method was used to directionally solidify the eutectic rods. The laser 
floating zone system consists of a CO2 semisealed laser of 600 W (Electronic Engineering, Firenze, 
Blade600, λ = 10.6 μm), and a home-made growth chamber fitted with gold coated metal mirrors for 
the beam focusing. The mirror system includes a reflaxicon that transforms the solid beam into a ring, 
which is deflected by a flat mirror at 45° and focused by a parabolic mirror onto the ceramic rod, 
undergoing homogeneous heating. The correct optical alignment is obtained with the aid of a red diode 
laser coaxial providing with the infrared beam. The ceramic rods were attached to the two vertical axis 
with independent rotation and translation movement. The growth process starts heating the lower end of 
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the precursor. Once a drop is formed a small seed placed in the lower axis is approached until a liquid 
bridge is established between the precursor and the seed. Then the seed is moved away at the same time 
as that the precursor is moved to the molten zone, maintaining constant volume of the liquid zone. 
The ceramic rods grew at a rate of 20 mm/h at counter rotation of ±15 rpm. Afterwards, the samples 
were annealed at 650 °C for 5 h in order to relieve the stress formed during the quenching process. 
Small cylindrical bioeutectic specimens, measuring 2.0 ± 0.1 mm in diameter and 10 ± 0.1 mm in length, 
were cut from the sintered bulk with a diamond saw. 
4.2. Animal and Surgical Procedure 
The experimental protocol was approved by the ethical committee of the University of Murcia 
following the local and European Regulations. 
Eight male adult New Zealand rabbits, weighing between 3.5 and 3.8 kg were divided into two 
groups of four (n1 = 4, n2 = 4) for experiments carried over 4 and 15 months. Both tibiae were  
used in the implantation procedure. The animals were anaesthetized by an intramuscularly (im)  
injection of Atropine sulphate, 0.3mg/kg; hydrochlorate of ketamine, 50mg/kg and hydrochloride of  
clorpromazine, 10 mg/k. 
Both legs were shaved and washed with Chlorhexidine®, then Betadine® was applied, and, finally, 
surgical area was covered with sterile drape. After that, an incision 1.2–1.5 cm in length was made in 
the medial aspect in proximal metaphysial area of each tibia. A bone defects sized 3 mm in diameter 
were created with spherical surgical drill connected to a micro-motor at low revolutions under continuous 
saline irrigation to avoid thermal damage to the bone [18]. Cylindrical implants were press fit in the 
defects to ensure stability. The implants were previously cleaned in sterile PBS solution, dried at 37 °C 
and sterilized with gas plasma. Afterwards, the wounds were closed using meticulous technique 
(anatomical layers) with continuous sutures (Vicryl™ 3/0 and Vicryl Rapid® 3/0). A single dose of 
antibiotic therapy (Amoxicilin 0.1 mg/kg/im) was carried out during pre-operative period. Over the 
next three days after the surgery Tolphenamic acide 0.1 mL/kg/via was administered subcutaneously 
every 12 h. At the end of 4 and 15 months periods, the animals were euthanized, under sedation 
(Hydrochlorate of Ketamina, 50 mg/kg/im), with an overdose of thiopental by via intracardiac. 
4.3. Decalcified and Undecalcified Preparations 
The tibia segments containing the implants were excised using a diamond saw 0.5 mm proximal 
and distal from the implant. Histological analysis was performed on the decalcified tissues. Half of the 
samples were fixed in 10% neutral formol and decalcified in Hydrochloric-polyvinylpyrrolidone 
(TBD-1) acid (Termo Shandon, Pittsburg, PA, USA). The decalcified samples were next cleaned and 
dehydrated in a series of graded ethanol solutions and embedded in paraffin. The regions containing 
implants were cut into 5 μm thick sections and stained with haematoxylin-eosin and Masson Trichrome 
for the optical microscopy study using a Leitz Orthoplant FSA microscope (Microscopy-UK, 
Wallington (Surrey), UK). 
The cross-sections of the undecalcified tissues were also examined by the Analytical Scanning 
Electron Microscopy (SEM). A Hitachi S-3500N Scanning electron microscopy (Hitachi, Ibaraki, 
Japan) fitted with an energy-dispersive spectrometer (EDS) (Inca-Oxford Instruments, High Wycombe, 
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UK) was used. Secondary electron imaging was performed at 20 keV on carbon coated specimens. 
These specimens were fixed in 3% glutaraldehyde after soaking in buffer solution overnight, post fixed 
in 1% osmium tetroxide for two hours at 4 °C, washed in 0.1 M cacodilate solution, dehydrated in a 
series of graded ethanol solutions and finally embedded in hydroxyethylmethacrylate resin. Each 
undecaldififed block was polished using 6 μm and then 1 μm diamond pastes. In addition, the 
chemistry of the interfaces was analyzed using X-ray elemental maps. The thickness measurements of 
the Ca-P layer formed around the implants were performed using back-scattered electron imaging at 
higher magnification range. Twenty measurements were taken from each sample totaling forty 
measurements per implantation period. 
The samples were also studied by μ-Raman microprobe instrument consisting of a Jobin Ivon 
T64000 spectrometer (Edison, NJ, USA) fitted with a microscope, which allows a spatial resolution on 
the sample close to 1 μm. The 488-nm line of an Ar+ laser was used as excitation, focused in a spot of 
~1 μm in diameter, with an incident power on the sample of ~2 mW. 
Morphological and structural identification of the newly-formed Ca-P phase formed at the interface 
was carried out using Transmission Electron Microscopy (TEM) technique. Bright field images were 
studied in conjunction with Selected Area Diffraction patterns (SAD). Jeol Jem 2010 microscope (Jeol 
Ltd., Tokio, Japan) was operated at 200 keV, and 80 cm camera length condition was applied for SAD 
patterns. Electron transparent thin sections for the study were prepared from the regions of close 
contact between the implant and new surface product. Reichert ultramicrotome fitted with diamond 
knife, operated at room temperature, was used for sectioning the material. Morphological study was 
performed on stained thin sections with saturated solution of uranyl acetate in ethanol and also 1% 
osmium acid solution in ethanol. Unstained sections were used for structural studies in SAD mode. 
5. Conclusions 
In vivo evaluation of the Bioeutectic® ceramic obtained by the laser floating zone method was 
determined by carried out implantation into tibia of adults New Zealand rabbits. With the limitations of 
this animal study, it maybe affirmed that Bioeutectic® ceramic is a biocompatible, bioactive, and 
osteoconductive material. The ceramic material promotes bone regeneration at the site of implantation, 
does not interfere with normal healing processes and provides an ideal matrix for establishing new 
bone formation. The Bioeutectic® ceramic implant appeared to act as a physical support where cells 
with osteoblastic capability were found to migrate and develop processes. These cells colonized the 
surface of the Bioeutectic® implant in contact with the bone and led to a direct deposition of a new 
bone, while the implant was undergoing phase transformation into the bone like phase. It is, thus, expected 
that the Bioeutectic® ceramic could be satisfactorily used for repair or replacement of living bone. 
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